PitchBook News

VC (finally) lands a glove on PE 🥊

SpaceX's pricey pivot

🍋 2021 was a lemon

AI's hot new target

Surgical robots break out

Secondary market’s heirs apparent

VC’s alchemists of AI

Silicon slump puts IPOs on ice

Bain vs. Carlyle: $7B wealth fight

Decacorns are the new unicorns

Bean counting for AI

Opportunities in AI hacking

When AI agents buy and sell

AI's true cost

When $188B is quaint

Self-learning factories

Stripe and Advent's lowball bid

NY's data center freeze

OpenAI's trillion-dollar wait

AI's musical chairs

VC firm buys your grandpa's fund

Record VC exits don't help all

Signs of a data center peak

Quantum computing's déjà vu

The VC hubs of the World Cup stage

Jersey Mike's serves up S-1 sub

Software wins for the taking

New Q2 VC data, new dashboard

Comcast splits as peers combine

Liquidity wiggles loose in Asia

Quantum leap

The Whoop-ification of the World Cup

Why AI isn't killing finance software

Beneath VC's splashy deals

Same round, different price tag

Solar surge

SpaceX's AI rocket fuel

Biggest VC-backed M&A ever

AI is scaring lenders from software

It's launch day

SpaceX watch party

Anthropic's metric to watch

AI IPOs are off to the races

Who's paying Trump's H-1B fee?

First to build the missile wins

OpenAI goes public as AI's worst value

The AI budget trap

Biotech IPOs get their groove back

VC's $2 trillion depends on 3 magic doors

Defense tech VC's graduation

SpaceX builds a lockup ladder

Music catalogs strike a chord

US private credit spreads widen

Can Oura jolt healthtech exits?

Liftoff: Your guide to SpaceX's S-1

What's drawing LPs back to China

Patent fight in VC secondaries

Charted: Anthropic vs. OpenAI

SpaceX's IPO wild card

Robots need insurance, too

Crossovers bet big before the bell

Microsoft sets OpenAI free

Venture debt hits decade high

Eli Lilly's $7B hedge against GLP-1s

Frontier labs come for biology

The business of GPU preorders

A race for the wealthy

OpenAI and Anthropic's ARR row

Defense tech's next IPO test

Software's new model

The incredible exploding AI budget

Lawsuits haunt 401(k) expansion

Reading Altman's fine print

The liquidity puzzle in interval funds

VC exit boom left most behind

Silicon Valley craze nears FDA nod

Weak science behind AI health hype

US carmarkers' futures ride on AI

Wealth advisers in the hot seat

Prediction markets: A regulatory gamble

The nuance behind evergreen funds

How to deploy $100B

RIP debt's golden era

Mapping AI's $244B market

SpaceX at Musk's mercy

The problem with mega IPOs

AI's builders and bankers

A winner-takes-most reality

Tether's new pastime